Hippo in Bristol & the South West

Headline numbers

Summary

Bristol and the South West is one of Hippo's strongest regional footprints — a diverse mix of urban Bristol practices and large multi-site networks serving rural Somerset communities. Across seven practices and over 93,000 registered patients, the region generated 5,555 appointments in 2025/26 at a consistent 31% response rate.

The region demonstrates Hippo's full operational range: from urban single-site practices running tightly-focused campaigns, to multi-site networks managing recall across tens of thousands of patients. Across the cohort, every major long-term condition register is being actively managed through Hippo — hypertension, pre-diabetes, asthma, COPD, cardiovascular disease — alongside preventive programmes including cervical screening, shingles and pneumococcal vaccination.

Campaign performance

Across the seven practices, the strongest-performing campaigns in 2025/26 were:

The pattern is consistent with the wider Hippo network: clinically urgent conditions (COPD, hypertension) generate the strongest patient engagement, while screening and behaviour-change programmes sit lower. The Bristol cohort outperforms the network average on hypertension and pre-diabetes campaigns specifically — suggesting strong engagement with cardiovascular and metabolic risk programmes across the region.

Channel performance

Across all seven practices, recalls were delivered via three primary channels:

NHS App leads on response rate — 41% across 1,388 sends — consistent with the network-wide pattern where digitally-engaged patients respond more readily to in-app notifications than to email or text.

A distinctive approach: questionnaire-integrated recall

One Bristol practice in the cohort uses Hippo's questionnaire integration to capture clinical data at the point of patient contact, rather than at the appointment itself. Recalls include a link to a structured questionnaire — capturing blood pressure readings, smoking status, or respiratory symptoms — which the patient completes before attending. Completed questionnaires are saved directly to EMIS, reducing the clinical time needed at the review appointment.

The response rates from this approach are notable: 50% on COPD reviews, 42% on asthma reviews, and 35% on a blood pressure campaign reaching 1,665 patients in a single year. Patients appear to engage positively when the recall message includes a clear, structured task they can complete on their own time — and the practice benefits from a faster, more focused review appointment when the patient does attend.

This is a model that any practice in Bristol or the South West considering Hippo could replicate — and one that increasingly defines what proactive care automation looks like at scale.

Multi-site scale

The largest practice network in the Bristol cohort serves over 80,000 patients across multiple sites in Somerset. In 2025/26, the network ran Hippo-driven recall across hypertension, non-diabetic hyperglycaemia, cervical screening, shingles and pneumococcal vaccination — managing thousands of patient contacts per campaign while maintaining consistent response rates across all sites. Hypertension recall reached a 53% response rate; non-diabetic hyperglycaemia reached 50%.

For a network of that size, the alternative to automated recall is significant operational burden: thousands of phone calls, letters, and ad-hoc texts per campaign cycle. Hippo replaces that work with a single configuration that scales across sites and runs continuously, freeing clinical and administrative staff to focus on the patients who actually book.

What the Bristol data shows

Seven practices. Consistent results. A range of approaches — from questionnaire-integrated single-site practices to multi-site networks running recall at population scale.

For practices in Bristol and the South West considering Hippo, the regional data offers a straightforward proof point: 31% response rates sustained across thousands of recalls, 5,555 appointments generated in a single year, and a platform flexible enough to support every major recall pattern a practice might want to run.

About Hippo

Hippo is an NHS healthtech company building proactive care automation tools for GP practices. Our platform automates patient recall, tracks QOF and LTC indicators, and optimises appointment demand — helping practices deliver better care with the capacity they already have.

Book a demo

Data accurate as of 31 March 2026. Figures based on 2025/26 contract year, aggregated across seven practices in the Bristol & South West region. No individual practices identified.